CD14 is a decision-maker between Fas-mediated death and inflammation
Signaling through classical death receptor Fas was mainly appreciated as a pro-death pathway until recent reports characterized pro-inflammatory outcomes of Fas-mediated activation in pathological contexts. How Fas signaling can switch to pro-inflammatory activation is poorly understood. Herein, we report that in macrophages and neutrophils, the Toll-like receptor (TLR) adapter CD14 determines the inflammatory output of Fas-mediated signaling. Our findings propose CD14 as a crucial chaperone of Fas receptor internalization in macrophages and neutrophils, resulting in Cd14<sup>-/-</sup> myeloid cells that are protected from FasL-induced apoptosis, activate nuclear factor κB (NF-κB), and release cytokines in response. As in TLR signaling, CD14 is also required for Fas to signal through the adaptor TRIF (TIR-domain-containing adapter-inducing interferon-β) and induce a pro-death complex. Our findings demonstrate that CD14 availability can determine the switch between Fas-mediated pro-death and pro-inflammatory outcomes by internalizing the receptor.
Authors
- Irina Smirnova
- Stephen C. Bunnell (ORCID: https://orcid.org/0000-0001-6887-0828)
- Hayley I. Muendlein (ORCID: https://orcid.org/0000-0003-3006-5780)
- Shruti Sharma (ORCID: https://orcid.org/0000-0001-8200-108X)
- Wilson M. Connolly
- David Jetton (ORCID: https://orcid.org/0000-0002-1615-9986)
- Alexander Poltorak (ORCID: https://orcid.org/0000-0002-5375-6587)
- Zoie Magri (ORCID: https://orcid.org/0000-0001-9378-4278)
- Hunter Russell
Institutions
- Tufts University (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.celrep.2024.114685
- Citations
- 8
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases